In conclusion, our data further confirm the predominant role of the SLCO1B1 c.521 C>T polymorphism in predisposing to statin‐induced myopathy in a “real‐world” patient population, in particular with simvastatin. The gene discussed is SLCO1B1; the disease is myopathy.